Clinical Trials on Rare Non-Neoplastic Disorder in France

Total 6592 results

Centre Hospitalier Universitaire de Nice

Completed

Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

Non Alcoholic Fatty Liver Disease

France
University Hospital, Montpellier

Completed

Comparison of Three Noninvasive Ventilation Modes: a Physiological Study in Healthy Volunteers

Respiratory Failure | Non Invasive Ventilation on Healthy Volunteer

France
Hospices Civils de Lyon
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Recruiting

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment (TROPHAMET)

Gestational Trophoblastic Neoplasias (GTN)

France
Institut Paoli-Calmettes

Recruiting

Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level (EUS-CTC)

Cancer of Pancreas

France
University Hospital, Angers

Recruiting

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction) (UDFF)

Non Alcoholic Fatty Liver Disease

France
Bayer

Completed

Copanlisib Pharmacodynamic Study

Non Hodgkin Lymphoma

Belgium, France, United Kingdom
University Hospital, Montpellier

Completed

Pharmacist for Detecting Opioid Misuse

Chronic Non Cancer Pain

France
Centre Hospitalier Universitaire de Nīmes

Completed

Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques

Metastatic Melanoma

France
Association pour la Recherche sur les Maladies...

Completed

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis (FLIRT)

Non Alcoholic Steatohepatitis

France
Innate Pharma

Recruiting

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

France, United States, Australia
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B (SCARA-B)

Breast Neoplasms

France
Centre Hospitalier Universitaire Dijon

Terminated

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours (EOLE)

Non-resectable Metastatic Cancer of the Lung | Non-resectable Metastatic Cancer of the Colon | Non-resectable Metastatic Cancer of the Rectosigmoid Junction | Non-resectable Metastatic Cancer of the Stomach | Non-resectable Metastatic Cancer of the Bile Duct | Non-resectable Metastatic Cancer... and other conditions

France
Janssen Research & Development, LLC
Pharmacyclics LLC.

Completed

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

CD20-positive B-cell Non-Hodgkin Lymphoma

United States, France
Centre Oscar Lambret

Recruiting

Feasibility of a New Technology for Isolating Circulating Tumour Cells (CTC-SMMiL-E)

Ovarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast Cancer

France
Centre Hospitalier Universitaire de Nice

Recruiting

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease (STEATO-APA)

Non-Alcoholic Fatty Liver Disease (NAFLD

France
Assistance Publique - Hôpitaux de Paris

Completed

Mexiletine and Non Dystrophic Myotonias (MYOMEX)

Myotonia Congenita | Paramyotonia Congenita | Non-dystrophic Myotonias

France
Assistance Publique - Hôpitaux de Paris
Institute of Cardiometabolism and Nutrition, France

Recruiting

NASH and Coronary Disease (CORO-NASH)

Non-Alcoholic Fatty Liver Disease

France
Sanofi

Terminated

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma (GRAAL2)

Hyperuricemia

Germany, Belgium, Italy, France
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
Lymphoma Study Association

Completed

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

Follicular Lymphoma

France
University Hospital, Bordeaux
Schering-Plough

Completed

PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) (EADO)

Melanoma | Neoplasm Metastasis

France
University Hospital, Toulouse

Recruiting

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease (BUCCONAFLD)

Non-Alcoholic Fatty Liver Disease

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors (VAPOR)

Non-Seminomatous Germ Cell Tumor

France
AstraZeneca

Terminated

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Spain, United States, Korea, Republic of, France, Portugal, Australia, Italy
University Hospital, Bordeaux

Completed

Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis (UVE-FAS)

Non-Infectious Active Uveitis

France
Hoffmann-La Roche

Completed

A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

France
Gilead Sciences

Terminated

Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)

Non-Hodgkin Lymphoma

United States, France
Nantes University Hospital

Withdrawn

Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients. (PENTI-MIDAS)

Multiple Myeloma

France
GlaxoSmithKline

Completed

Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Lymphoma, Non-Hodgkin

United States, France, United Kingdom
Gilead Sciences

Completed

Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma | Lymphoma, Diffuse | Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic

France, United Kingdom
Institut Paoli-Calmettes

Unknown

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Lymphoma, B-Cell

France
French Innovative Leukemia Organisation
Mundipharma Pte Ltd.; Janssen, LP

Completed

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma (ManteauRiBVD)

Lymphoma

France
University Hospital, Montpellier

Recruiting

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) (CTC-AXL-PANC)

Pancreatic Ductal Adenocarcinoma | Circulating Tumor Cell | Metastatic Pancreatic Cancer

France
Gilead Sciences
Ono Pharmaceutical Co. Ltd

Completed

Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL

Chronic Lymphocytic Leukaemia | Non Hodgkins Lymphoma

United Kingdom, France
Assistance Publique - Hôpitaux de Paris

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment. (MRD-CONFIRM)

Multiple Myeloma

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) (LIFSCREEN)

Li Fraumeni Syndrome

France
French Innovative Leukemia Organisation
Lymphoma Study Association

Completed

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Mantle Cell Lymphoma

France
French Innovative Leukemia Organisation
Mundipharma Pte Ltd.; Roche Pharma AG; Janssen-Cilag Ltd.; Lymphoma Study Association and other collaborators

Completed

Study of Mantle Cell Lymphoma Treatment by RiBVD (RIBVD)

Mantle Cell Lymphoma

France
French Innovative Leukemia Organisation

Completed

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

Follicular Lymphoma

France
Hospices Civils de Lyon

Active, not recruiting

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas. (BCL6-RINHL)

Follicular Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma

France
Photocure

Terminated

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Cervical Intraepithelial Neoplasia

France, Germany, Norway
Genentech, Inc.

Completed

A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

Lymphoma, Non Hodgkin

United States, France
Lymphoma Study Association

Unknown

Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Lymphoma

United Kingdom, France
French National Agency for Research on AIDS and...

Terminated

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

HIV Infections | Lymphoma, Non-Hodgkin

France
Boehringer Ingelheim

Recruiting

A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Neoplasm Metastasis | Non-Small Cell Lung Cancer

United States, Hong Kong, Spain, Korea, Republic of, China, Israel, Germany, Japan, Singapore, Australia, United Kingdom, Austria, Netherlands, France, Portugal, Sweden, Italy, Belgium
Hospices Civils de Lyon

Recruiting

Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis (Profil-NASH)

Liver Diseases

France
Hospices Civils de Lyon

Recruiting

Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) (INOVOLINE)

Breast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cancer Metastatic

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension (APIS)

Intrahepatic Non Cirrhotic Portal Hypertension

France
Celgene

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of CC-95775 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

France, Spain
Bristol-Myers Squibb

Active, not recruiting

A Rollover Study of CC-122

Non-Hodgkin Lymphoma

Netherlands, France, United States, Japan

Clinical Trials on Rare Non-Neoplastic Disorder in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations